Astellas is already a proven player in the fields of Transplantation, Urology, Dermatology, Anti-Infectives and Pain Management – a position we have achieved through a commitment to innovation. We are now bringing this expertise to bear in the field of oncology.
With approximately 20% of our sales being invested into research, we are dedicated to building a strong presence in this most challenging of therapeutic areas where a high level of unmet medical need exists.
Already we have no fewer than 12 separate therapies under clinical development. Through these programmes, we aim to fulfil not just our potential, but our promise to change tomorrow for patients suffering with conditions such as prostate cancer, other solid tumours such as pancreatic and breast cancer, advanced renal cell carcinoma and haematological malignancies.